Publications Leading and supporting collaborative research to advance global immunisation policy and practice Filter PublicationsReports Year1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024 All categoriesAboriginal and Torres Strait Islander healthAdverse eventsAnnual coverage reportAustralian Immunisation Register related studiesAusVaxSafetyCOVID-19COVID-19 in educational settings studyDiphtheriaEmerging infectionsFestschrift and generalGeneral surveillanceGlobal healthHaemophilus influenzae type bHajj and mass gatheringsHealth economicsHepatitis AHepatitis BHistoryHuman papillomavirusImmunisation coverageImmunisation policy and practiceImmunisation reviewsInfluenzaMeaslesMeningococcal diseaseMonkeypoxMumpsNCIRS 20th anniversaryOther vaccine preventable and infectious diseasesPaediatric Active Enhanced Disease Surveillance (PAEDS)PertussisPharmacist vaccinationPneumococcal diseasePoliomyelitisQ feverRefugee healthRespiratory Disease - GeneralRespiratory syncytial virus (RSV)RotavirusRubellaSocial researchSpecial risk groupsSurveillanceTetanusVaccine safetyVaccine trialsVaricella-zoster Update Publications Year Category - Any -Aboriginal and Torres Strait Islander healthAdverse eventsAnnual coverage reportAustralian Immunisation Register related studiesAusVaxSafetyCOVID-19COVID-19 in educational settings studyDiphtheriaEmerging infectionsFestschrift and generalGeneral surveillanceGlobal healthHaemophilus influenzae type bHajj and mass gatheringsHealth economicsHepatitis AHepatitis BHistoryHuman papillomavirusImmunisation coverageImmunisation policy and practiceImmunisation reviewsInfluenzaMeaslesMeningococcal diseaseMonkeypoxMumpsNCIRS 20th anniversaryOther vaccine preventable and infectious diseasesPaediatric Active Enhanced Disease Surveillance (PAEDS)PertussisPharmacist vaccinationPneumococcal diseasePoliomyelitisQ feverRefugee healthRespiratory Disease - GeneralRespiratory syncytial virus (RSV)RotavirusRubellaSocial researchSpecial risk groupsSurveillanceTetanusVaccine safetyVaccine trialsVaricella-zoster Sharma K, Perrett K, Wood N. Case Series: Yellow fever vaccination in egg-allergic children. Pediatric Infectious Disease Journal. 2020;39:e76-e78. doi: 10.1097/INF.0000000000002625. [Full text] Totterdell J, Phillips A, Glover C, Chidwick K, Marsh J, Snelling T, Macartney K. Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program. Vaccine. 2020;38:3968-3979 . [Full text] Pillsbury AJ, Fathima P, Quinn HE, Cashman P, Blyth CC, Leeb A, Macartney K . Comparative post-market safety profile of adjuvanted and high-dose influenza vaccines in the elderly. JAMA Open. 2020;3(5):e204079 . [Full text] Deng L, Mab A, Wood N, Ardern-Holmes S. Vaccination management in an asymptomatic child with a novel SCN1A variant and family history of status epilepticus following vaccination: a case report on a potential new direction in personalised medicine. Seizure: European Journal of Epilepsy. 2020;78:49-52 . [Full text] Leong NR, Wooda JG, Liu B, McIntyre PB, Newall AT . High healthcare resource utilisation due to pertussis in Australian adults aged 65 years and over. Vaccine. 2020;38:3553–3559 . [Full text] Frank O, Bernardo C, Gonzalez-Chica DA, Macartney K, Menzies R, Stocks N . Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Human Vaccines & Immunotherapeutics. 2020;16:965-971 . [Full text] Netfa F, Tashani M, Booy R, King C, Rashid H, Skinner SR. Knowledge, Attitudes and perceptions of immigrant parents towards human papillomavirus (HPV) vaccination: a systematic review . Tropical Medicine and Infectious Disease. 2020;5:58 . [Full text] Kaufman J, Attwell K, Tuckerman J, O'Sullivana J, Omar SB, Leask J, Regan A, Marshal H, Leea KJ, Snelling T, Perrett K, Wiley K, Giles ML, Danchin M. Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: a pilot study. Vaccine. 2020;38:4024-4031 . [Full text] Wnukowski-Mtonga P, Jayasinghe S, Chiu C, Macartney K, Brotherton J, Donovan B, Hall M, Smith D, Peterson K, Campbell-Lloyd S, Selvey C, Gilles M, Kaldor J, Marshall H. Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia by the Australian Technical Advisory Group on Immunisation (ATAGI) . Communicable Diseases Intelligence. 15 April 2020. 2020;44 . [Full text] Beard F, Hendry A, Macartney K . Influenza vaccination uptake in our most vulnerable groups: how well are we protecting them in 2019? . Communicable Diseases Intelligence. 15 April 2020. 2020;44 . [Full text] Pagination Previous page You're on Page 22 Next page 42283 views